Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Multi-institutional Retrospective Analysis of Carbon-ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix

Noriyuki Okonogi
,
Ken Ando
,
Kazutoshi Murata
* ORCID logo ,
Masaru Wakatsuki
,
Shin-ei Noda
,
Daisuke Irie
,
Hiroshi Tsuji
,
Makio Shozu
ORCID logo ,
Tatsuya Ohno
ORCID logo
Version 1 : Received: 10 April 2021 / Approved: 12 April 2021 / Online: 12 April 2021 (12:51:36 CEST)

How to cite: Okonogi, N.; Ando, K.; Murata, K.; Wakatsuki, M.; Noda, S.; Irie, D.; Tsuji, H.; Shozu, M.; Ohno, T. Multi-institutional Retrospective Analysis of Carbon-ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix. Preprints 2021, 2021040302. https://doi.org/10.20944/preprints202104.0302.v1 Okonogi, N.; Ando, K.; Murata, K.; Wakatsuki, M.; Noda, S.; Irie, D.; Tsuji, H.; Shozu, M.; Ohno, T. Multi-institutional Retrospective Analysis of Carbon-ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix. Preprints 2021, 2021040302. https://doi.org/10.20944/preprints202104.0302.v1

Abstract

The clinical significance of carbon-ion radiotherapy (CIRT) for adenocarcinoma (AC) of the uterine cervix has been assessed in several single-institutional studies. To validate the significance, we conducted a multi-institutional survey of CIRT for locally advanced AC (LAAC) of the uterine cervix. We retrospectively analyzed the clinical outcomes of patients with stage IIB–IVA LAAC of the uterine cervix who underwent chemo-CIRT or CIRT alone between April 2010 and April 2016. Patients received 74.4 Gy (relative biological effectiveness [RBE]) in 20 fractions of CIRT or 55.2 Gy (RBE) in 16 fractions of CIRT plus 3 sessions of brachytherapy. Patients aged ≤70 years with adequate bone marrow and organ function were administered cisplatin weekly (40 mg/m2 per week for up to 5 weeks). Fifty-five patients were enrolled in this study. The median follow-up period was 67.5 months. The 5-year overall survival (OS) and local control (LC) rates were 68.6% and 65.2%, respectively. Multivariate analysis showed that the initial tumor response within 6 months was significantly associated with LC and OS. The present study represents promising outcomes of CIRT or chemo-CIRT for LAAC of the uterine cervix, especially in the cases showing initial rapid regression of the tumor.

Keywords

carbon-ion radiotherapy; uterine cervical cancer; adenocarcinoma; long-term follow-up; cisplatin; concurrent chemoradiotherapy

Subject

Medicine and Pharmacology, Immunology and Allergy

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.